bokomslag Handbook on Immunosenescence
Kropp & själ

Handbook on Immunosenescence

Tamas Fulop Claudio Franceschi Katsuiki Hirokawa Graham Pawelec

Inbunden

4459:-

Funktionen begränsas av dina webbläsarinställningar (t.ex. privat läge).

Uppskattad leveranstid 10-16 arbetsdagar

Fri frakt för medlemmar vid köp för minst 249:-

Andra format:

  • 1693 sidor
  • 2009
Immunosenescence is an imprecise term used to describe deleterious age-associated changes to immune parameters observed in all mammals studied so far. It represents a rapidly progressing science in the aging field, with a vertiginous volume of new data, knowledge and concepts concerning these changes. We are poised to be in a position to translate these accumulated data into the clinical setting via better understanding of the contribution of immunosenescence to age-associated pathologies, and their prevention by appropriate interventions. This authoritative handbook seeks to encompass the current state of our knowledge on the multitude of those changes to immunity related to aging, with contributions from experts in the research and clinical areas. This book therefore considers methods and models for studying immunosenescence; cellular immunosenescence of T cells, B cells, neutrophils, antigen presenting cells, NK, NKT and stem cells; genetics; mechanisms including receptors and signal transduction; mitochondria; proteasome; cytokines; neuro-endocrine-immune networks; inflammation; thymus; clinical relevance in disease states including infections, autoimmunity, cancer, metabolic syndrome, neurodegenerative diseases, frailty and osteoporosis; modulation by nutrition, lipids, vaccination and the question can interventions to influence immunosenescence be realistically proposed based on our current state of knowledge?
  • Författare: Tamas Fulop, Claudio Franceschi, Katsuiki Hirokawa, Graham Pawelec
  • Format: Inbunden
  • ISBN: 9781402090622
  • Språk: Engelska
  • Antal sidor: 1693
  • Utgivningsdatum: 2009-02-25
  • Förlag: Springer-Verlag New York Inc.